Featured Research

from universities, journals, and other organizations

Zebrafish model helps identify drug compound that reverses lethal form of cardiomyopathy

Date:
June 11, 2014
Source:
Beth Israel Deaconess Medical Center
Summary:
Investigators have identified a drug compound that appears to reverse arrhythmogenic cardiomyopathy using a zebrafish model. This condition is a hereditary disease and leading cause of sudden death in young people. It damages the muscle of the heart’s ventricles (the pumping chambers) so that, over time, muscle cells or myocytes, become replaced by fatty deposits and fibrosis, leaving patients especially susceptible to arrhythmias.

Using a zebrafish model, investigators have identified a drug compound that appears to reverse arrhythmogenic cardiomyopathy (ACM), a hereditary disease and leading cause of sudden death in young people. The findings, led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Brigham and Women’s Hospital, provide a key first step in developing new therapies for this dangerous condition, for which there is currently no preventive treatment.

Related Articles


The study appears in the June 11 issue of Science Translational Medicine.

“For some individuals, ACM has no symptoms or warning signs, meaning that the first and only manifestation of disease is sudden death,” explains corresponding author Jeffrey E. Saffitz, MD, PhD, Chairman of the Department of Pathology at BIDMC and Mallinckrodt Professor of Pathology at Harvard Medical School. The condition affects approximately 1 in 5,000 individuals worldwide, often striking patients under age 35.

ACM damages the muscle of the heart’s ventricles (the pumping chambers) so that, over time, muscle cells or myocytes, become replaced by fatty deposits and fibrosis, leaving patients especially susceptible to arrhythmias. Once an arrhythmia develops, the heartbeat becomes rapid and erratic causing the victim to grow dizzy or collapse – and in the most serious cases to suffer sudden cardiac death.

“There are currently no drugs available that can reliably prevent arrhythmias and sudden death in ACM,” explains Saffitz. Patients who exhibit frequent arrhythmias or experience repeated fainting spells are considered to be at risk for sudden death, and often undergo implantation of an automatic cardiac defibrillator (ICD) which continuously monitors the heart rhythm and delivers a shock to the heart if it detects a potentially lethal rhythm abnormality.

“While ICDs can be life-saving, they are expensive and can create a serious psychological burden for the patient,” adds Saffitz. “Waiting for a life-threatening arrhythmia to develop and then relying on a device to stop it by delivering a painful shock is not the ideal way to manage this condition. We have to find drugs that can prevent the arrhythmia from occurring in the first place.”

To identify the mechanisms underlying this dangerous disease and to find potential drugs to prevent its onset, co-senior author Calum A. MacRae, MD, PhD, a geneticist in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital created a screenable zebrafish model of ACM with cardiac myocyte-specific expression of a human mutation in the gene encoding plakoglobin, which is known to cause ACM in humans. By working with zebrafish, which develop rapidly and can be produced in large quantities, the investigators could see clear evidence of heart disease after only 48 hours of embryonic development.

They then conducted a high-throughput screen to test 4,800 chemicals to identify a suppressor of the disease phenotype. One chemical in particular, SB216763, showed a remarkable ability to prevent or reverse the disease in fish. Armed with this new information, the investigators confirmed their findings through studies of both mammalian models of ACM and human heart muscle cells derived from adult stem cells from ACM patients.

“We found that a single small molecule [SB216763] could reverse both the muscle cell injury and the arrhythmia components of ACM,” says Saffitz. These new findings provide strong evidence that these complex disease processes are linked to a common mechanism, which appears to involve a defect in forward trafficking of key proteins to the intercalated disc, sites of cell-cell adhesion.

“It also appears that we have discovered a new mechanism-based anti-arrhythmic drug that can prevent or reverse major abnormalities of cellular electrophysiology in the heart in cases of ACM,” says Saffitz. “This work shows that it is possible to model a complex human disease in fish and use high-throughput screens of large chemical libraries for the discovery of effective new drugs and could help provide the foundation for future chemical biology efforts to bring such drugs to clinical use.”


Story Source:

The above story is based on materials provided by Beth Israel Deaconess Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Angeliki Asimaki, Sudhir Kapoor, Eva Plovie, Anne Karin Arndt, Edward Adams, Zhenzhen Liu, Cynthia A. James, Daniel P. Judge, Hugh Calkins, Jared Churko, Joseph C. Wu, Calum A. Macrae, Andrι G. Klιber, and Jeffrey E. Saffitz. Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy. Science Translational Medicine, June 2014 DOI: 10.1126/scitranslmed.3008008

Cite This Page:

Beth Israel Deaconess Medical Center. "Zebrafish model helps identify drug compound that reverses lethal form of cardiomyopathy." ScienceDaily. ScienceDaily, 11 June 2014. <www.sciencedaily.com/releases/2014/06/140611143655.htm>.
Beth Israel Deaconess Medical Center. (2014, June 11). Zebrafish model helps identify drug compound that reverses lethal form of cardiomyopathy. ScienceDaily. Retrieved February 28, 2015 from www.sciencedaily.com/releases/2014/06/140611143655.htm
Beth Israel Deaconess Medical Center. "Zebrafish model helps identify drug compound that reverses lethal form of cardiomyopathy." ScienceDaily. www.sciencedaily.com/releases/2014/06/140611143655.htm (accessed February 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, February 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could a $34 Smartphone Device Improve HIV Diagnosis in Africa?

Could a $34 Smartphone Device Improve HIV Diagnosis in Africa?

Reuters - Innovations Video Online (Feb. 27, 2015) — A dongle that plugs into a Smartphone mimics a lab-based blood test for HIV and syphilis and can detect the diseases in 15 minutes, say researchers. Tara Cleary reports. Video provided by Reuters
Powered by NewsLook.com
Doctor Says Head Transplants Possible Within Two Years

Doctor Says Head Transplants Possible Within Two Years

Buzz60 (Feb. 27, 2015) — An Italian doctor is saying he could stick someone&apos;s head onto someone else&apos;s body. Patrick Jones (@Patrick_E_Jones) reports. Video provided by Buzz60
Powered by NewsLook.com
How Your Dentist Could Help Screen You For Diabetes

How Your Dentist Could Help Screen You For Diabetes

Newsy (Feb. 27, 2015) — A new study from researchers at New York University suggests dentists could soon use blood samples taken from patients&apos; mouths to test for diabetes. Video provided by Newsy
Powered by NewsLook.com
The Best Tips to Makeover Your Health

The Best Tips to Makeover Your Health

Buzz60 (Feb. 27, 2015) — If you&apos;re looking to boost your health this season, there are a few quick and easy steps to prompt you for success. Krystin Goodwin (@Krystingoodwin) has the best tips to give your health a makeover this spring! Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins